Khan, H.; Zamzam, A.; Shaikh, F.; Mamdani, M.; Saposnik, G.; Qadura, M.
HE4 as a Prognostic Biomarker of Major Adverse Cardiovascular Events in Patients with Abdominal Aortic Aneurysm: A Canadian Prospective Observational Study. Biomedicines 2025, 13, 1562.
https://doi.org/10.3390/biomedicines13071562
AMA Style
Khan H, Zamzam A, Shaikh F, Mamdani M, Saposnik G, Qadura M.
HE4 as a Prognostic Biomarker of Major Adverse Cardiovascular Events in Patients with Abdominal Aortic Aneurysm: A Canadian Prospective Observational Study. Biomedicines. 2025; 13(7):1562.
https://doi.org/10.3390/biomedicines13071562
Chicago/Turabian Style
Khan, Hamzah, Abdelrahman Zamzam, Farah Shaikh, Muhammad Mamdani, Gustavo Saposnik, and Mohammad Qadura.
2025. "HE4 as a Prognostic Biomarker of Major Adverse Cardiovascular Events in Patients with Abdominal Aortic Aneurysm: A Canadian Prospective Observational Study" Biomedicines 13, no. 7: 1562.
https://doi.org/10.3390/biomedicines13071562
APA Style
Khan, H., Zamzam, A., Shaikh, F., Mamdani, M., Saposnik, G., & Qadura, M.
(2025). HE4 as a Prognostic Biomarker of Major Adverse Cardiovascular Events in Patients with Abdominal Aortic Aneurysm: A Canadian Prospective Observational Study. Biomedicines, 13(7), 1562.
https://doi.org/10.3390/biomedicines13071562